Trade Talks

Chad P. Bown
undefined
Nov 2, 2022 • 60min

170. National security, semiconductors, and the US move to cut off China

The history behind the sudden US ban on certain exports to China, and how the policy affects the global semiconductor supply chain.
undefined
Oct 25, 2022 • 31min

169. Taiwan's risky trade opening and how it paid off

In the 1950s, Taiwan was the first poor economy to experiment with trade reform. How its success changed the course of history for others.
undefined
Oct 10, 2022 • 23min

168. Did Trump's trade war make China more protectionist?

Why it matters that Chinese public opinion toward trade and technology may have changed in response to US policy.
undefined
Oct 3, 2022 • 30min

167. Will new US tax credits remake electric vehicle supply chains?

America's new EV subsidies have some carmakers upset. Others are head scratching. Can supply chains diversify away from China?
undefined
Sep 21, 2022 • 45min

166. Biden's new Indo-Pacific talks vs. TPP

America's last attempt at trade talks with countries in the region ended badly. How Biden's IPEF approach is different.
undefined
Sep 5, 2022 • 46min

165. The global minimum tax got left behind. What's next?

The Inflation Reduction Act omits the key global minimum corporate tax agreed to by over 135 countries. Will cooperation still happen?
undefined
Jul 27, 2022 • 39min

164. Why a notorious banana company spared workers in Costa Rica

For decades, United Fruit Company exploited banana workers across its Latin American plantations, except in Costa Rica. Why?
undefined
Jul 19, 2022 • 38min

163. How poorer Americans ended up paying for US tariffs.

From fashion to forks to fishing reels, how US trade negotiations starting in the 1930s resulted in regressive import duties today.
undefined
Jul 5, 2022 • 40min

162. Poor countries could once enforce WTO trade. That is now at risk.

The Advisory Centre on WTO Law made trade enforcement possible for poor countries. The Appellate Body crisis put that under threat.
undefined
Jun 26, 2022 • 42min

161. Why sharing patents for COVID-19 medicines is not enough

Despite the Medicines Patent Pool, COVID-19 treatments remain scarce globally. Prashant Yadav explains what more is needed.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app